MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28

Medinotec Inc.

Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026

$5.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $58.78M
P/E (TTM): –
Dividend yield: –

Medinotec Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-02-28	FY 2025 2025-02-28	FY 2024 2024-02-29	FY 2023 2023-02-28	FY 2022 2022-02-28
Cash & Equivalents	2.76	2.77	2.81	2.83	0.13
Cash & Short-Term Investments	2.76	2.77	2.81	2.83	0.13
Receivables	2.35	2.61	0.59	0.02	0.04
Prepaid Expenses & Other	0.05	0.05	0.04	–	–
Other Current Assets	0.07	0.05	0.12	0.17	0.11
Total Current Assets	6.42	6.42	4.38	3.37	0.72
Property, Plant & Equipment	0.33	0.35	0.32	0.41	0.52
Gross Property, Plant & Equipment	1.64	1.64	1.55	1.72	1.99
Accumulated Depreciation	-1.43	-1.33	-1.27	-1.41	-1.51
Machinery & Equipment	1.15	1.14	1.06	1.10	0.18
Operating Lease Right-of-Use Assets	0.01	0.04	0.06	–	–
Total Assets	6.81	6.81	4.80	4.49	1.32
Accounts Payable	1.09	1.48	0.80	0.07	0.21
Current Portion of Leases	0.01	0.03	0.02	–	–
Total Current Liabilities	1.10	1.51	0.83	0.07	–
Long-Term Debt	0.00	0.94	1.77	1.86	–
Long-Term Leases	–	0.01	0.04	–	–
Operating Lease Liabilities	0.01	0.04	0.06	–	–
Deferred Tax Liabilities	–	0.08	–	–	–
Total Liabilities	1.10	2.54	2.64	1.93	1.79
Total Debt	0.00	0.94	1.77	1.86	–
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3.41	3.30	3.30	3.30	–
Comprehensive Income & Other	0.58	0.04	0.10	0.08	0.00
Shareholders' Equity	5.71	4.27	2.17	2.56	-0.47
Noncontrolling Interest	1.71	0.92	-1.24	-0.84	-0.48
Total Equity	5.71	4.27	2.17	2.56	-0.47
Total Liabilities & Equity	6.81	6.81	4.80	4.49	1.32
Shares Outstanding(shares)	12	12	12	12	10
Loans, Net	–	–	–	0.61	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Aug 31, 2026

Profitability, TTM

Gross margin: 49.6%
Operating margin: 6.6%
Net margin: 5.8%
Return on equity, FY2026: 15.9%

Financial strength

Current ratio: 6.74
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 270.5%

Valuation

P/E ratio: –
Price to sales: 5.76
Price to book: 9.91
Dividend yield: –